Shanghai Xuerong Biotechnology Co.,Ltd. (SHE:300511)

SHE:300511 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	104.97	167.95	252.67	363.82	340.77	759.89
Short-Term Investments	-	-	0.06	-	-	-
Trading Asset Securities	-	-	-	270	-	-
Cash & Short-Term Investments	104.97	167.95	252.72	633.82	340.77	759.89
Cash Growth	-45.64%	-33.54%	-60.13%	86.00%	-55.16%	163.85%
Accounts Receivable	36.33	31.39	33.48	29.02	28.86	23.79
Other Receivables	5.78	5.55	6.28	50.13	18.89	27.51
Receivables	42.11	36.95	39.76	79.15	47.74	51.3
Inventory	373.45	325.34	442.86	443.28	384.08	382.65
Prepaid Expenses	-	2.9	5.74	3.97	2.11	5
Other Current Assets	24.71	13.17	25.51	32.34	100.24	29.54
Total Current Assets	545.23	546.31	766.6	1,193	874.94	1,228
Property, Plant & Equipment	2,726	2,965	3,460	2,579	2,945	2,785
Long-Term Investments	12.01	15.6	16.24	21.46	32.61	13.49
Other Intangible Assets	295	299.63	306.9	221.72	328.38	256.58
Long-Term Deferred Tax Assets	-	-	-	-	12.83	7.81
Long-Term Deferred Charges	6.12	7.91	21.81	26.48	47.77	86.04
Other Long-Term Assets	16.84	19.87	30.68	30.82	95.96	170.23
Total Assets	3,601	3,855	4,602	4,072	4,337	4,548
Accounts Payable	326.86	298.35	318.15	215.87	214.13	161.26
Accrued Expenses	40.68	78.07	66.92	61.84	55.59	83.84
Short-Term Debt	320.34	967.85	1,036	575.76	777.49	650
Current Portion of Long-Term Debt	233.42	146.19	168.69	170.4	248.23	225.08
Current Portion of Leases	-	1.05	4.01	1.13	1.07	8.98
Current Income Taxes Payable	6.55	-	-	-	0.01	-
Current Unearned Revenue	13.09	20.62	7.16	16.23	14.15	9.87
Other Current Liabilities	412.15	436.11	512.47	256.29	295.98	246.08
Total Current Liabilities	1,353	1,948	2,113	1,298	1,607	1,385
Long-Term Debt	786.78	960.21	948.27	973.69	954.69	1,048
Long-Term Leases	21.28	21.45	24.41	23.45	23.45	-
Long-Term Unearned Revenue	58.52	60.56	51.12	43.89	49.68	60
Other Long-Term Liabilities	32.96	40.78	33.08	107.64	51.12	48.57
Total Liabilities	2,253	3,031	3,170	2,446	2,686	2,542
Common Stock	627.06	498.82	498.78	503.04	441.92	442.03
Additional Paid-In Capital	1,258	741.98	741.82	753.99	471.77	484.22
Retained Earnings	-430.33	-367.98	249.09	437.16	724.38	1,070
Treasury Stock	-	-	-	-16.43	-34.7	-52.5
Comprehensive Income & Other	2.18	65.81	64.83	65.51	65.98	73.1
Total Common Equity	1,457	938.63	1,555	1,743	1,669	2,017
Minority Interest	-108.13	-115.31	-122.15	-117.43	-17.5	-11.2
Shareholders' Equity	1,349	823.32	1,432	1,626	1,652	2,006
Total Liabilities & Equity	3,601	3,855	4,602	4,072	4,337	4,548
Total Debt	1,362	2,097	2,181	1,744	2,005	1,932
Net Cash (Debt)	-1,257	-1,929	-1,928	-1,111	-1,664	-1,172
Net Cash Per Share	-2.28	-3.88	-3.90	-2.28	-3.85	-2.70
Filing Date Shares Outstanding	627.06	498.82	498.78	503.04	507.6	439.17
Total Common Shares Outstanding	627.06	498.82	498.78	503.04	441.92	439.17
Working Capital	-807.85	-1,402	-1,346	-104.97	-731.7	-156.74
Book Value Per Share	2.32	1.88	3.12	3.47	3.78	4.59
Tangible Book Value	1,162	638.99	1,248	1,522	1,341	1,761
Tangible Book Value Per Share	1.85	1.28	2.50	3.02	3.03	4.01
Buildings	-	2,316	2,283	1,929	1,922	1,785
Machinery	-	2,687	2,598	2,187	2,209	2,161
Construction In Progress	-	53.49	360.31	68.28	151.74	122.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.